Gene expression profiling has identified two major molecular subtypes of diffuse large B-cell lymphoma (DLBCL) that are histologically indistinguishable but differ in cure rates. Here, we investigated whether the isotype of the B-cell receptor (BCR) expressed by the tumoral cells correlated with the molecular subtype and survival. Gene expression analysis clustered the 53 patients included in this study into three subgroups, 17 germinal center B-cell-like (GCB) cases, 26 activated B-celllike (ABC) cases and 10 intermediate cases. The molecular subtype was correlated with the isotype, as 15/17 GCB cases expressed a secondary isotype (immunoglobulin (Ig)G or IgA), whereas 24/26 ABC cases expressed a primary isotype (IgM or IgD) (Po0.0001). There was a trend toward a worse outcome for patients with an ABC DLBCL and a shorter overall survival for patients with IgM þ tumor (P ¼ 0.21 and 0.014, respectively). Finally, fluorescence in situ hybridization (FISH) analysis revealed a striking asymmetric pattern, as the IGHM gene is conserved only on the productive IGH allele in most IgM þ tumors. Taken together, these data indicate that the isotype of the BCR is a reliable indicator for the GCB and ABC subtypes in DLBCL, and suggest that the conservation of an IgM is required for ABC DLBCL lymphomagenesis to occur.
Introduction
Investigations using DNA microarrays have shown that diffuse large B-cell lymphomas (DLBCL) group into at least two histologically indistinguishable, but molecularly distinct pathologies that differ in response to chemotherapy and cure rates. 1 The first, termed germinal center B-cell like (GCB), is associated with the best prognosis and has a gene expression profile reminiscent of normal germinal center B cells. The second, termed activated B-cell like (ABC), is associated to a poor prognosis and has a gene expression profile of late GC B cells.
This classification could be of considerable value within the context of clinical trials and in everyday diagnostics, but most laboratories are unable to discriminate these pathologies in routine practice. This limitation is attributed to the cost of global gene expression profiling experiments, the difficulty in interpreting the data in the standard workup of DLBCL and to the poor inter-laboratory reproducibility of the immunohistochemical algorithms developed to distinguish between these pathologies. 2, 3 As an alternative method, a gene expression-based approach that uses a limited set of genes has been proposed. 4, 5 This set includes classical B-cell markers, such as CD10, LMO2, IRF4 or BCL6, which are differentially expressed in ABC and GCB DLBCLs. Interestingly, the set also includes the IGHM gene, which is transcribed at higher levels in ABC cases, suggesting that a majority of these tumors may still express an IgM. Concurrently, further work has shown that a majority of GCB cases have internal rearrangements within the IGH locus compatible with the expression of a secondary isotype, suggesting that these tumors may have performed normal isotype switching. 6 Taken together, these observations have led to the hypothesis that the two major subtypes of DLBCL may express different immunoglobulin heavy chains, 6, 7 which raises the possibility that the isotype of the B-cell receptor (BCR) could be a relevant biomarker to differentiate between these pathologies.
Still, from many aspects, the possibility that the isotype could correlate with the molecular subtype in DLBCLs appears self-contradictory. For example, it is difficult to reconcile the expression of an IgM with the observation that these lymphomas often express the activation-induced cytidine deaminase enzyme, which is directly responsible for the initiation of isotype class switching in normal B cells. 6, 8 Adding to this paradox, it was reported that more than 50% of these tumors have illegitimate junctions within the switch regions (S), suggesting that the isotype switching process has been activated during lymphomagenesis, but has, for some unknown reason, failed to modify the BCR itself. 6 To explain this surprising observation, it was proposed that some intrinsic defect of the class switch recombination (CSR) machinery could prevent normal class switching and favor the accumulation of genetic abnormalities during the course of lymphomagenesis. Nevertheless, the same study also revealed that one-third of ABC DLBCLs indeed have legitimate junctions between the Sm and a downstream S region, suggesting that these tumors may express a secondary isotype. Furthermore, in one-third of the GCB cases in this study, such junctions were not found, suggesting that these cases may have retained the expression of an IgM. Thus, as the defect of class switching may not occur systematically in ABC DLBCL, and as many GCB cases may not have undergone isotype class switching, the correlation between the molecular subtype and the isotype could be severely biased.
To clarify this issue, we directly addressed the hypothesis that the isotype of the BCR could predict the molecular subtype and the progression in DLBCL. In a series of 53 cases treated in our institution, we correlated the isotype of the BCR determined by reverse transcription-polymerase chain reaction (RT-PCR) with the gene expression signature and the clinical outcome, and analyzed the structure of the IGH loci.
Patients and methods

Patient materials
Fifty-three previously untreated patients were included in this study. Biological material was obtained after receiving patient consent. This study was approved by the institutional review board of the Centre Henri Becquerel. Inclusion criteria included the availability of genomic DNA, total RNA and paraffinembedded tissues obtained from lymph node biopsies at the time of diagnosis. DNA was extracted using proteinase K, followed by salt and ethanol precipitation and stored at À20 1C in 10 mM Tris-Cl 1 mM EDTA (pH 8) buffer. RNA was isolated using the RNA NOW kit (Biogentex, Seabrook, TX, USA) and stored at À80 1C in water. Synthesis of cDNA was performed using Moloney murine leukemia virus reverse transcriptase (Invitrogen, Carlsbad, CA, USA). Only tumors for which we could characterize the VDJ exon independently from the genomic DNA and from total RNA were included in this study, which ensured that the biopsies corresponded to true tumoral regions and validated the integrity of the nucleic acid materials. Overall survival was measured from the date of biopsy to the date of death from any cause. It was expressed as Kaplan-Meier plots and analyzed by the log-rank test.
Characterization of the BCR
VDJ exons were characterized according to the BIOMED-2 guidelines with some modifications. 9 PCR was performed from genomic DNA with VH-FR1 or VH-Leader primers coupled with the JH primer using the 2 Â Hot-Goldstar Mix (Eurogentec, Seraing, Belgium). RT-PCR amplifications were performed from total mRNA using Cm, Cd, Cg, Ca1, Ca2 and Ce primers (Supplementary Table 1 ). Products were purified using the QIAquick kit (Qiagen, Valencia, CA, USA) and sequenced using an ABI PRISM 3130 analyzer (Applied Biosystems, Foster City, CA, USA). Sequences were analyzed using the IMGT/V-QUEST tools. 10 
Immunochemistry
Immunohistochemical characterizations were performed on formalin-fixed lymph nodes using standard protocols. 2 
Gene expression profiling
We designed a custom VeraCode DASL gene expression assay (Illumina, San Diego, CA, USA) to identify each case as belonging to either the GCB or ABC subtype. 4, 5 This assay includes 19 genes that are differentially expressed in ABC (IGHM, FOXP1, SH3BP5, IRF4, IL16, BLNK, ENTPD1 (CD39), ETV6 (TEL), CCND2, PIM1, FUT8 and PTPN1) and GCB (MME (CD10), LRMP, NEK6, BCL6, LMO2, ITPKB and MYBL1) DLBCLs. Unsupervised hierarchical clustering was performed using 'COR' distances (opposite of Pearson's r) after Cubic Spline normalization (GenomeStudio V2009.1 software, Illumina). To obtain an independent correlation, the IGHM gene was excluded from the clustering analysis.
Fluorescence in situ hybridization (FISH)
A (FISH) probe binding at 14q32 was prepared from the BAC clone RP11-862G15. The probe binding at the Cm-Cg3 intergenic region was prepared by mixing seven PCR products amplified from normal human genomic DNA (Roche, Nutley, NJ, USA) using the primers described in Supplementary Table 1 . Probes were labeled with Spectrum-Green and Orange dUTP (Vysis, Downers Grove, IL, USA) and hybridized to metaphase chromosomes according to the manufacturer's recommendations. Images were captured using a Metafer4 platform (MetaSystems, Altlussheim, Germany).
Genomic PCR and sequence reactions
Genomic PCR amplifications were performed using a highfidelity enzyme (Extensor Hi-Fidelity PCR master Mix, ABgene, Epsom, UK). The PCR primers are described in Supplementary  Table 1 . PCR products were visualized on agarose gels, purified using the QIAquick purification kit and sequenced. To address the allele-specific distribution of the internal Sm deletions, the region extending from the VDJ exon to the 5 0 Sm region was amplified using the VH-FR1 and SmREV primers. The PCR products were sequenced using the Seq primer.
Results
Characterization of the molecular subtype by gene expression profiling
To identify each case as belonging to either the GCB or ABC subtypes, we evaluated the expression of 18 genes that are differentially expressed in these two pathologies, 4,5 using a custom DASL gene expression assay. Unsupervised hierarchical clustering analysis classified these genes into the two expected independent subsets ( Table 1 ). However, this algorithm being associated to an important degree of uncertainty, 2, 3 we used only the ABC/GCB classification obtained by DASL gene expression profiling throughout this study.
VH gene mutation analysis
In agreement with previous work, 11 clonal and in-frame VDJ rearrangements without stop codons were detected in almost all of the DLBCL specimens (GenBank accession nos. HQ392869-HQ392921 and Supplementary Table 2 ). Sequencing data disclosed a significant bias with regard to the use of the VH4 family, which was over-represented in the ABC cases (11/26 or 42.3 vs 2/15 or 13.3% in ABC and GCB cases, respectively, P ¼ 0.045, Fisher's exact test) and of the VH3 family, which was over-represented in the GCB cases (14/17 or 82.4% vs 10/26 or 38.5% in GCB and ABC cases, respectively, P ¼ 0.0003, Fisher's exact test) ( Table 1 ). All of the VH gene sequences contained somatic mutations with a median percentage of 12.2%. The analysis of these mutations revealed that the GCB cases have a higher mutation frequency than the ABC cases (median mutation frequency of 9.4 vs 16.1% in ABC and GCB cases, respectively, P ¼ 0.002, Mann-Whitney test).
The isotype of the BCR correlates with the molecular subtype and with survival DNA microarrays experiments have revealed that the IGHM gene is expressed at higher level in ABC cases than that in GCB cases, 4 a result we could further validate in the largest cohort of DLBCL patients reported so far (Figures 2a and b) . 12 The DASL gene expression assay also confirmed this finding in our series of patients (Figure 2c ). To test whether this correlation is a direct consequence of these lymphomas expressing different immunoglobulin heavy chains, we next characterized the isotype of the BCR by clonally rearranged-specific RT-PCR. We used PCR primers specific to the VH genes identified from the DNA samples and to the different constant genes, and confirmed the specificity of all amplifications by sequencing analysis. In this series, 15/17 (88.2%) of the GCB cases expressed a secondary isotype (14 IgG and 1 IgA) and 24/26 (92.3%) of the ABC cases expressed a primary isotype (23 IgM and 1 IgD), showing that the GCB and ABC molecular subtypes and the isotype of the BCR are correlated (Po10 À6 , Fisher's exact test) ( Figure 1 and Table 1 ). As shown in Figure 2d , the results of the DASL gene expression assay confirm that the IGHM gene is expressed at higher level in the group of IgM þ tumors. However, a significant expression was also detected in some IgG/A þ cases, probably due to the presence of reactive B cell in the crude biopsies. Finally, if the GCB signatures showed only a nonsignificant trend toward longer survival in this series, the expression of an IgM identified by clonally rearranged-specific RT-PCR was significantly associated with a shorter survival ( Figure 3 ).
The IGHM gene is deleted from the non-productive IGH allele in a majority of ABC DLBCLs
To clarify the extent of isotype switching in these pathologies, we next addressed the structure of the IGH loci. We generated a red-labeled FISH probe that covers the Cm-Cg3 region, which corresponds to the minimal region deleted during normal isotype switching (Figure 4a ). We used a second green-labeled probe that was centromeric to the IGH locus to identify the chromosomes. 13 These probes were co-hybridized to cell metaphases from 33 tumors for which cytogenetic materials were available (Figure 4b, Supplementary Figures 1-4 Large internal deletions within the Sm region occur exclusively in IgM þ DLBCLs and cluster on the productive IGH loci
The asymmetrical profile we observed in a majority of IgM þ cases suggests that the defect that prevents isotype switching in these tumors occurs specifically on the productive IGH locus. Thus, this observation raises the possibility that some element necessary for isotype switching may have been inactivated on this allele. Remarkably, large deletions within the Sm region, which have been proposed to participate in the stabilization of IgM in several other mature B-cell malignancies, [13] [14] [15] have also been shown to occur frequently in ABC DLBCLs. 6 To test the hypothesis that these deletions may play a role during the (Figure 5b and Table 1 ). To obtain further insights into the functional relevance of these deletions, we addressed their allelic distribution. Owing to the technical difficulty in amplifying the whole Sm region, which results from the presence of repeated sequences at both the 5 0 and at the 3 0 ends, we adopted a two-step strategy and used the mutations that accumulate at the 5 0 end of the region during the activation of class switching as allelic markers. In the 16 cases that showed Abbreviations: ABC/GCB, molecular subtypes identified by DASL gene expression profiling; ACVBP, doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone followed by consolidation; Auto., autologous transplantation; Del., deletions within the Sm region; CHOP, doxorubicin, cyclophosphamide, vincristine, prednisone; F, fusion of the green and red signals; FISH, fluorescence in situ hybridization; G, green signal identifying the 14q32 region; % Hom., percentage of homology with the corresponding germline VH gene; Ig, immunoglobulin; Immuno., GCB and non-GCB phenotypes identified by immunochemistry according to the Hans predictor; int, interediate between ABC and GCB; Isotype, isotype of the BCR identified by RT-PCR; mini-CHOP, attenuated CHOP; n.a., not available; NCVBP, mitoxantrone, cyclophosphamide, vinblastine, bleomycine, prednisone; n.i., not informative; n.t., not tested; Proto., inclusion protocol; R, red signal identifying the Cm-Cg3 region; R, rituximab; Treat., treatment regimen; UPN, unique patient number; VH, variable gene usage referred according to the IMGT nomenclature.
an internal Sm deletion, we first aimed to amplify the regions that extend from the VH segment to the 5 0 Sm region. Amplifications were obtained in 10 cases. We sequenced the 3 0 end of these PCR products, which corresponds to the 5 0 Sm region. We next sequenced the same 5 0 Sm region starting from the short SmF-Cm PCR product. In all cases, the same somatic mutations were identified, showing that the internal Sm deletions cluster specifically on the productive IGH alleles.
Discussion
This study shows that the high expression of the IGHM gene in ABC DLBCLs revealed by gene expression profiling 4 translates for a majority of cases into the expression of functional IgMs. Conversely, our data show that the lower level of expression of this gene in GCB DLBCLs is a result of a majority of these lymphomas expressing a secondary isotype. Our data also provide further evidence that the isotype of the BCR not only correlates with the GCB and ABC molecular subtypes in DLBCL, but also with the outcome. This correlation is consistent with a recent report where the expression of an IgM was associated with the worst prognosis in a large series of nodal DLBCL cases. 16 It is also consistent with the observation that this isotype predominates in rare and aggressive forms of lymphomas, such as primary central nervous system, 15 primary testicular 17 and primary cutaneous DLBCL, 18, 19 which all have an ABC-like phenotype. Isotype class switching in DLBCL P Ruminy et al
The correlation between the molecular subtype and the isotype of the BCR highlights an important paradox between the differentiation stage, also termed cell of origin, of the two major subtypes of DLBCL and the isotype of the BCR. Although GCB DLBCLs are thought to develop from GC B cells, our data further suggest that the tumoral cells have reached a later stage of maturation during the transformation process, in which isotype class switching has occurred. By contrast, the demonstration that almost all ABC DLBCLs, which otherwise have a late GC Bcell gene expression profile and express activation-induced cytidine deaminase enzyme, still express an IgM further highlights the hypothesis that a defect of isotype class switching is essential for the development of this pathology. 6 Our analysis of the configuration of the IGH loci provides new insights into the molecular mechanisms responsible for the absence of isotype class switching in this disease. The asymmetric deletion of the IGHM gene in a majority of the IgM þ cases contrasts strikingly with the symmetric pattern seen in normal post-GC B cells, which usually exhibit switching to the same isotype on the productive and non-productive alleles. 22, 23 This asymmetry indicates that the CSR defect is specific to the productive IGH locus, suggesting that it does not result from a global failure of the CSR machinery. Interestingly, a similar pattern has been observed in transgenic mice lacking the Sm repeats. These animals have a significant defect of isotype class switching, show asymmetrical deletions of the Cm gene in post-GC B cells and, like ABC DLBCLs, accumulate aberrant junctions within the S regions. [24] [25] [26] The observation that the large internal deletions within the Sm region, which are particularly frequent in IgM þ DLBCLs, cluster on the productive IGH alleles may thus provide a mechanistic explanation for the resistance of these tumors to isotype switching. We hypothesize that the loss of a large part of the Sm region may occur frequently during ABC DLBCL lymphomagenesis, during early CSR attempts. This loss would occur when the two IGH loci are in germline configuration and would participate in the stabilization of IgM. Next, subsequent CSR activation would result in the excision of the IGHM gene from the non-productive allele without being able to modify the heavy chain of the immunoglobulin. This unusual asymmetrical profile, which is reminding of the configuration of the IGH loci in many follicular lymphomas, 14 also suggests that the functional IGH allele is under strong selective pressure to preserve the expression of IgM at all stages of lymphomagenesis. It can thus be asked what crucial selective advantage may be provided to the pre-lymphoma cells by a stabilization of an IgM. If it has long been assumed that the cytoplasmic tail of the immunoglobulin heavy chain was too short to interfere with the transduction of the signal, it was recently shown that almost half of the antigen-induced gene responses in B cells were significantly diminished when the cytoplasmic tail of IgM was substituted with one of an IgG. 27 This attenuation results in the decreased expression of many genes that oppose plasma-cell differentiation, including IRF4, suggesting that isotype switching is crucial for the terminal differentiation of GC B cells. Thus, it can be speculated that the resistance of ABC DLBCL cells to the expression of a secondary isotype may participate in blocking those cells in a dangerous stage where activation-induced cytidine deaminase enzyme, which is directly induced by IRF4, 28 and the class switch recombination process are active and represent a potent threat to the integrity of the genome. Given that the NFkB pathway, which plays a central role in this pathology, mediates the transduction of the signals from the BCR to IRF4, the stabilization of IgM may also participate directly in the survival of the tumoral cells. 29 Finally, if the different data sets we analyzed all confirm that the level of expression of the IGHM gene is significantly higher in ABC cases when large populations are considered, 4 our data also indicate that this level does not allow a reliable identification of the isotype of the BCR in individual cases. A significant mRNA expression remaining detectable in many IgMÀ cases in our series, resulting probably from the presence of normal reactive B cells in the crude biopsy samples, the use of additional techniques like the one we developed with clonally rearranged VDJ-specific RT-PCR or alternative flow cytometry assays, appears to be mandatory to characterize the isotype of the immunoglobulin heavy chain that is expressed by the lymphoma cells. We thus propose that these techniques, which can be performed in most institutions, could be incorporated in future prospective clinical trials to further address the correlation between the isotype of the BCR and the molecular subtypes, and its relevance as a prognostic marker. The PCR products were separated on an agarose gel. Neg: negative PCR control; Ctrl: PCR amplification product from a pool of normal genomic DNA. Tumoral samples are identified by their UPN. Under standard conditions, the SmF-Cm PCR does not allow for the amplification of the Sm region owing to the presence of long GC-rich internal repeats.
